ey0016.7-16 | Treatment | ESPEYB16
PB Kaplowitz
, PF Backeljauw
, DB Allen
To read the full abstract: Horm Res Paediatr. 2018;90(1):17.The authors discuss why GnRH analog therapies should not be used in all girls with central precocious puberty (CPP), but only in those cases where the predicted benefits outweigh the risks and high cost of the treatment.Epidemiological studies in Europe and USA show declining average a...